Literature DB >> 10967756

Three-field lymphadenectomy for esophageal cancer.

N K Altorki1.   

Abstract

Esophagectomy with three-field lymph node dissection can be performed with a mortality and morbidity similar to that of less extensive operations. Approximately one third of patients will have previously unsuspected metastasis to the recurrent laryngeal nodes. This pattern of spread seems to be independent of cell type or tumor location. The impact of the procedure on patient survival is unclear; however, our early results are encouraging.

Entities:  

Mesh:

Year:  2000        PMID: 10967756

Source DB:  PubMed          Journal:  Chest Surg Clin N Am        ISSN: 1052-3359


  4 in total

1.  The first series of completely robotic esophagectomies with three-field lymphadenectomy: initial experience.

Authors:  K H Kernstine; D T DeArmond; D M Shamoun; J H Campos
Journal:  Surg Endosc       Date:  2007-06-26       Impact factor: 4.584

2.  Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis.

Authors:  Jia Yu; Wenyu Hu; Nan Yao; Mengzi Sun; Xiaotong Li; Ling Wang; Yixue Yang; Bo Li
Journal:  Transl Oncol       Date:  2021-05-18       Impact factor: 4.243

Review 3.  Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis.

Authors:  Richard A Malthaner; Rebecca Ks Wong; R Bryan Rumble; Lisa Zuraw
Journal:  BMC Med       Date:  2004-09-24       Impact factor: 8.775

Review 4.  Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guideline.

Authors:  Richard A Malthaner; Rebecca K S Wong; R Bryan Rumble; Lisa Zuraw
Journal:  BMC Cancer       Date:  2004-09-24       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.